Makers Laboratories Limited Stock Price Today (NSE: MAKERSL)
Fundamental Score
Makers Laboratories Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Makers Laboratories Limited share price today is ₹177.92, up +2.39% on NSE/BSE as of 16 September 2026. Makers Laboratories Limited (MAKERSL) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹88.06 (Cr). The 52-week high for MAKERSL share price is ₹236.00 and the 52-week low is ₹150.00. At a P/E ratio of 38.76x, MAKERSL is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 3.17% and a debt-to-equity ratio of 0.12.
Makers Laboratories Limited Share Price Chart — NSE/BSE Historical Performance
Makers Laboratories Limited share price chart: 16.39% return over the past month. 52-week high ₹236.00, 52-week low ₹150.00.
Makers Laboratories Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹174.98 | ₹179.98 | ₹174.98 | ₹177.92 | 376.00 (Cr) | |
| ₹184.95 | ₹187.20 | ₹171.36 | ₹173.77 | 4.84K (Cr) | |
| ₹177.05 | ₹189.00 | ₹175.98 | ₹185.87 | 4.05K (Cr) | |
| ₹188.45 | ₹191.00 | ₹176.98 | ₹177.97 | 8.85K (Cr) | |
| ₹184.28 | ₹191.00 | ₹183.00 | ₹184.89 | 1.30K (Cr) | |
| ₹191.00 | ₹191.00 | ₹182.01 | ₹184.63 | 1.23K (Cr) | |
| ₹195.45 | ₹195.45 | ₹176.20 | ₹186.75 | 2.56K (Cr) | |
| ₹206.85 | ₹206.85 | ₹188.40 | ₹189.90 | 6.51K (Cr) | |
| ₹188.00 | ₹200.97 | ₹182.06 | ₹200.77 | 9.97K (Cr) | |
| ₹188.48 | ₹188.48 | ₹181.60 | ₹182.70 | 1.96K (Cr) |
Makers Laboratories Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹185.30 | ₹206.85 | ₹171.36 | ₹177.92 | -3.98% | |
| ₹153.00 | ₹236.00 | ₹149.15 | ₹185.19 | +21.04% | |
| ₹148.80 | ₹168.50 | ₹144.25 | ₹149.05 | +0.17% | |
| ₹163.30 | ₹178.00 | ₹138.00 | ₹145.85 | -10.69% | |
| ₹140.35 | ₹186.70 | ₹140.35 | ₹163.75 | +16.67% | |
| ₹130.65 | ₹168.00 | ₹130.65 | ₹141.05 | +7.96% | |
| ₹142.90 | ₹171.00 | ₹133.60 | ₹135.20 | -5.39% | |
| ₹128.00 | ₹164.70 | ₹116.05 | ₹146.30 | +14.30% | |
| ₹123.45 | ₹129.00 | ₹112.10 | ₹119.50 | -3.20% | |
| ₹125.00 | ₹125.00 | ₹109.00 | ₹118.15 | -5.48% | |
| ₹122.00 | ₹139.15 | ₹117.15 | ₹120.20 | -1.48% | |
| ₹130.00 | ₹144.90 | ₹119.00 | ₹121.85 | -6.27% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Makers Laboratories Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Makers Laboratories Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MAKERSL across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Robust Profit Growth (2825.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (15.43% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (49.27% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (49.27% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.12)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (13.88x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 3.22)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (61.27%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Below-Average Return on Equity (3.17%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (9.28%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Limited Institutional Interest (FII+DII: 0.39%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Makers Laboratories Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Makers Laboratories Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Makers Laboratories LimitedMakers Laborato...Selected✓ MAKERSL • 506919 | 53.2/100 | ₹177.92₹178 | ₹88.06₹88.06 | 38.76Average 38.8 Average | 3.17%Poor 3.17% Poor | 9.28%Poor 9.28% Poor | 0.12Excellent 0.1 Excellent | 49.27%Excellent 49.27% Excellent | 15.43%Excellent 15.43% Excellent | 0.00% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1851.00₹1851 | ₹444110.43₹444110.43 | 36.73Average 36.7 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9395.00₹9395 | ₹248967.50₹248967.50 | 85.25Average 85.2 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4946.00₹4946 | ₹167402.32₹167402.32 | 79.01Average 79.0 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1116.90₹1117 | ₹111466.62₹111466.62 | 24.89Average 24.9 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1373.50₹1374 | ₹110958.20₹110958.20 | 32.91Average 32.9 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1947.50₹1948 | ₹105213.69₹105213.69 | 96.13Average 96.1 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1667.20₹1667 | ₹95930.69₹95930.69 | 26.05Average 26.1 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1143.90₹1144 | ₹95515.65₹95515.65 | 29.57Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2082.70₹2083 | ₹95231.46₹95231.46 | 17.21Average 17.2 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2253.70₹2254 | ₹93077.81₹93077.81 | 45.54Average 45.5 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price444110.43 Cr
- Divi's Laboratories Limited share price248967.50 Cr
- Torrent Pharmaceuticals Limited share price167402.32 Cr
- Zydus Lifesciences Limited share price111466.62 Cr
- Cipla Limited share price110958.20 Cr
Makers Laboratories Limited Dividend History
Annual cash dividends paid by MAKERSL — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2024 | ₹0.63 Cr |
| FY 2023 | ₹0.63 Cr |
| FY 2022 | ₹0.63 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Makers Laboratories Limited Quarterly Performance
Latest quarterly metrics for MAKERSL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
5.46%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
2825.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
15.43%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
49.27%
Compounded annual net profit growth over 5 years
Makers Laboratories Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MAKERSL — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Makers Laboratories Limited Financial Statements
Annual income statement, balance sheet and cash flow for Makers Laboratories Limited (MAKERSL) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Makers Laboratories Limited
About MAKERSL (Makers Laboratories Limited)
Makers Laboratories Ltd is a dynamic pharmaceutical entity deeply rooted in the Indian healthcare landscape, committed to developing, manufacturing, and distributing a diverse port...folio of pharmaceutical products. Operating with a dual focus, the company strategically divides its operations into two synergistic segments: pharmaceutical formulations and chemical manufacturing. This integrated approach enables Makers Laboratories to maintain stringent quality control throughout the entire production process, from the sourcing of raw materials to the final packaged product, ensuring patient safety and therapeutic efficacy. The company relentlessly pursues innovation, investing in research and development to create effective and affordable healthcare solutions tailored to the specific needs of the Indian population. The core of Makers Laboratories' success lies in its comprehensive range of therapeutic products, designed to address a broad spectrum of health concerns. The company offers solutions for common ailments and chronic conditions, including treatments for digestive disorders, infections, allergies, respiratory issues, and metabolic imbalances. Specifically, their product line features medications targeting acid reflux, parasitic worms, allergic reactions, asthma, bacterial infections, diabetes, diarrhea, nausea, fungal infections, hypertension, inflammation, pain, muscle spasms, malaria, and thyroid imbalances. This wide-ranging portfolio demonstrates Makers Laboratories' dedication to providing accessible and reliable healthcare solutions to meet the diverse medical needs of the Indian populace. Driven by a commitment to ethical business practices and unwavering quality standards, Makers Laboratories strives to enhance the well-being of individuals and communities. The company actively seeks to expand its reach and impact by leveraging its manufacturing capabilities, distribution networks, and strategic partnerships. With a strong emphasis on customer satisfaction and continuous improvement, Makers Laboratories remains dedicated to strengthening its position as a trusted provider of high-quality pharmaceutical products in the Indian market. They aspire to be a vital contributor to a healthier and more prosperous India.
Company Details
Key Leadership
MAKERSL Share Price: Frequently Asked Questions
What is the current share price of Makers Laboratories Limited?
Makers Laboratories Limited (MAKERSL) trades at ₹177.92 on NSE and BSE. Market cap ₹88.06 (Cr). Educational data only.
What is the P/E ratio of Makers Laboratories Limited?
Makers Laboratories Limited has a P/E of 38.76x vs industry average 34.89x.
What is the Bull Run score for Makers Laboratories Limited?
Makers Laboratories Limited has a Bull Run score of 53.2/100 based on 25+ financial parameters.
Does Makers Laboratories Limited pay dividends?
Makers Laboratories Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Makers Laboratories Limited?
Makers Laboratories Limited has ROE of 3.17%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Makers Laboratories Limited?
Makers Laboratories Limited has debt-to-equity of 0.12.
Is Makers Laboratories Limited a good investment?
Bull Run gives Makers Laboratories Limited a score of 53.2/100. This is not investment advice — consult a SEBI-registered advisor.